MIX MEETING TYPE.
| No. |
Proposition |
|
For |
Against |
Abstain |
| 1 |
Approval of the company financial statements for the 2025/2026 financial year |
|
|
|
|
| 2 |
Approval of the consolidated financial statements for the 2025/2026 financial year |
|
|
|
|
| 3 |
Appropriation of income and setting of the dividend |
|
|
|
|
| 4 |
Option to pay the dividend in shares |
|
|
|
|
| 5 |
Agreements covered by Articles L.225-38 et seq. of the French Commercial Code |
|
|
|
|
| 6 |
Reappointment of Forvis Mazars as Statutory Auditors |
|
|
|
|
| 7 |
Renewal of Sonia Bonnet-Bernard’s term of office as a Board member |
|
|
|
|
| 8 |
Renewal of Laure HriardDubreuil’s term of office as a Board member |
|
|
|
|
| 9 |
Approval of the information regarding the compensation ofcorporate officers paid during or awarded in respect of the2025/2026 financial year referred to in Article L.22-10-9 I ofthe French Commercial Code |
|
|
|
|
| 10 |
Approval of the components of the total compensation and benefits of any kind paid during, or awarded in respect of, the financial year ended 31 March 2026, to Marie-Amlie de Leusse, Chairwoman of the Board of Directors, in accordance with Article L.22-10-34 of the French Commercial Code |
|
|
|
|
| 11 |
Approval of the components of total compensation and benefits of any kind paid during or awarded to ric Vallat, Chief Executive Officer, in respect of the financial year ended 31 March 2026, pursuant to Article L. 22-10-34 of the French Commercial Code |
|
|
|
|
| 12 |
Approval of the components of total compensation and benefits of any kind paid during or awarded to Franck Marilly, Chief Executive Officer, in respect of the financial year ended 31 March 2026, pursuant to Article L. 22-10-34 of the French Commercial Code |
|
|
|
|
| 13 |
Approval of the compensation policy for the Chairman of the Board of Directors for the 2026/2027 financial year |
|
|
|
|
| 14 |
Approval of the compensation policy for the Chief Executive Officer for the 2026/2027 financial year |
|
|
|
|
| 15 |
Approval of the compensation policy for Board members for the 2026/2027 financial year |
|
|
|
|
| 16 |
Authorisation for the Board of Directors to trade in the Company’s shares |
|
|
|
|
| 17 |
Authorisation enabling the Board of Directors to reduce the share capital via the cancellation of treasury shares held by the Company |
|
|
|
|
| 18 |
Delegation of authority to the Board of Directors to issue ordinary shares and/or marketable securities giving access to the Company’s share capital and/or marketable securities giving rights to the allocation of debt securities, with maintenance of shareholders’ preferential subscription rights |
|
|
|
|
| 19 |
Delegation of authority to the Board of Directors to issue ordinary shares and/or marketable securities giving access to the Company’s share capital and/or marketable securities giving rights to the allocation of debt securities, with cancellation of shareholders’ preferential subscription rights, by public offering |
|
|
|
|
| 20 |
Delegation of authority to the Board of Directors to issue ordinary shares and/or marketable securities giving access to the share capital and/or marketable securities giving rights to the allocation of debt securities, with cancellation of shareholders’ preferential subscription rights, through private placements referred to in paragraph 1 of Arti |
|
|
|
|
| 21 |
Authorisation for the Board of Directors to increase the number of securities to be issued in the event of excess demand, up to a limit of 15% of the initial issue, with maintenance or cancellation of shareholders’ preferential subscription rights |
|
|
|
|
| 22 |
Delegation of authority to the Board of Directors to issue ordinary shares and/or marketable securities giving access to the share capital and/or marketable securities giving rights to the allocation of debt securities, with cancellation of shareholders’ preferential subscription rights, in the event of a public exchange offer initiated by the Comp |
|
|
|
|
| 23 |
Delegation of authority to the Board of Directors to issue ordinary shares and marketable securities giving access to the capital in consideration for contributions in kind granted to the Company, up to the limit of 10% of the share capital |
|
|
|
|
| 24 |
Delegation of authority to the Board of Directors to increase the capital by incorporation of reserves, profits or premiums |
|
|
|
|
| 25 |
Delegation of authority to the Board of Directors to carry out a capital increase reserved for employees of the Company or companies related to it, with cancellation of preferential subscription rights |
|
|
|
|
| 26 |
Harmonisation of the Articles of Association with various legal and regulatory provisions arising out of the Law of 13 June 2024, known as the “loi Attractivit” |
|
|
|
|
| 27 |
Powers to carry out formalities |
|
|
|
|